Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
A 110.06 0.15% 0.16
EW closed up 0.15 percent on Wednesday, July 28, 2021, on 68 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Jul 29
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical EW trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
New 52 Week High Strength 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 0.15%
Older End-of-Day Signals for EW ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Edwards Lifesciences Corporation Description

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Clinical Medicine Surgery Catheter Infection Irvine Oxygen Catheters Drainage Artery Perfusion Incision Cardiac Surgery Repair Products Cannula Cardiac Monitoring Heart Disease Heart Valve Care Products Heart Ricard Cardiac Output Edwards Embolectomy Heart Valves Edwards Lifesciences Heart Valve Disease Valvular Heart Disease

Is EW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 110.78
52 Week Low 70.92
Average Volume 2,347,231
200-Day Moving Average 89.38
50-Day Moving Average 101.67
20-Day Moving Average 106.97
10-Day Moving Average 107.41
Average True Range 1.88
ADX 28.96
+DI 31.22
-DI 15.41
Chandelier Exit (Long, 3 ATRs) 105.14
Chandelier Exit (Short, 3 ATRs) 107.39
Upper Bollinger Bands 110.58
Lower Bollinger Band 103.37
Percent B (%b) 0.93
BandWidth 6.74
MACD Line 2.04
MACD Signal Line 2.01
MACD Histogram 0.0342
Fundamentals Value
Market Cap 68.59 Billion
Num Shares 623 Million
EPS 1.27
Price-to-Earnings (P/E) Ratio 87.00
Price-to-Sales 12.31
Price-to-Book 12.62
PEG Ratio 3.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 112.07
Resistance 3 (R3) 112.09 111.43 111.74
Resistance 2 (R2) 111.43 110.92 111.43 111.62
Resistance 1 (R1) 110.75 110.61 111.09 110.73 111.51
Pivot Point 110.09 110.09 110.27 110.09 110.09
Support 1 (S1) 109.41 109.58 109.75 109.39 108.61
Support 2 (S2) 108.75 109.27 108.75 108.50
Support 3 (S3) 108.07 108.75 108.39
Support 4 (S4) 108.05